WellAir’s Defend 400 Reduces Airborne Bacteria


WellAir’s Defend 400 Reduces Airborne Bacterias

When found in an urgent treatment outpatient facility, WellAir’s Defend 400 decreased airborne bacteria significantly, according to new research.

WellAir has launched real-entire world test outcomes demonstrating how its Defend 400 gadget reduced airborne bacterias at an urgent treatment outpatient facility in NJ. When compared to control, the Defend 400 considerably reduced airborne germs in the mixed four areas by 52% and decreased opportunistic pathogens by 60% over a five-day time period.

The aim of the study, operate by WellAir and analyzed by EMSL Analytical Inc, was to find out if the Defend 400 would reduce airborne bacterial counts in comparison with the control (no gadget) within an urgent treatment outpatient service occupied by physicians, nurses, staff, and individuals.    

“Our Defend 400 gadget has been proven to reduce contaminants safely and successfully in lots of independent laboratory tests. The next phase has been to validate those results in a real-globe setting further,” mentioned Felipe Soberon, WellAir’s Chief Technology Officer. “This information showcases the efficacy of our options in healthcare conditions where people are continuously going and coming. In these spaces, high-quality indoor surroundings is crucial to patient supplier and outcomes protection.”

The analysis was conducted within November 2021 in the NJ urgent care outpatient service that has been running at normal capability and actively treating sufferers. The testing was carried out in a number of locations: an examination area, nurse station, break space, and waiting area within the facility. How big is the conditions ranged from 96 to 896 square foot.

Through the five consecutive times, the Defend 400 considerably reduced overall bacterial count by 52%, including a 60% decrease in opportunistic pathogens and a 43% decrease in pathogenic bacterias.

Decrease in airborne pathogens may reduce transmitting of airborne transmitted infectious illnesses at healthcare establishments. In 2021 laboratory tests , the Defend 400 demonstrated the opportunity to decrease the concentration of energetic SARS-CoV-2 from the air flow at typically 49.20% reduction after a quarter-hour and 99.86% after 45 minutes. A 2020 intervention research of two ICU devices using WellAir’s Protect 800/900 and Defend 1050 discovered that atmosphere purifiers, as well as the hospital HVAC techniques, may be a good way to decrease the microbial load in the surroundings and surfaces and therefore hospital-acquired infections. Further research must demonstrate this.

The Defend 400 can be an FDA-cleared Course II medical gadget that mixes WellAir’s patented NanoStrike™ Technologies with a triple-stage filtering from Camfil®. These devices complements existing infection avoidance practices such as for example built-in air and heating system conditioning systems, social distancing, surface and hand disinfection, and the usage of masks.

The Defend 400 is currently. Just click here to learn more on WellAir’s FDA-cleared air flow cleaning systems,.

Just click here for more service management news linked to healthcare amenities.
Menu